LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAD0.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $61,701,000 | +28.1% | 17,500,000 | 0.0% | 0.34% | +15.3% |
| Q2 2018 | $48,149,000 | +25.8% | 17,500,000 | 0.0% | 0.29% | +18.1% |
| Q1 2018 | $38,265,000 | +67.0% | 17,500,000 | +40.0% | 0.25% | +112.8% |
| Q4 2017 | $22,910,000 | +0.5% | 12,500,000 | 0.0% | 0.12% | -33.5% |
| Q3 2017 | $22,799,000 | +9.7% | 12,500,000 | 0.0% | 0.18% | +14.3% |
| Q2 2017 | $20,783,000 | +10.9% | 12,500,000 | 0.0% | 0.15% | +4.8% |
| Q1 2017 | $18,732,000 | +85.2% | 12,500,000 | +78.6% | 0.15% | +83.8% |
| Q4 2016 | $10,116,000 | -1.4% | 7,000,000 | 0.0% | 0.08% | +9.6% |
| Q3 2016 | $10,263,000 | -13.4% | 7,000,000 | 0.0% | 0.07% | -12.0% |
| Q2 2016 | $11,855,000 | +10.9% | 7,000,000 | 0.0% | 0.08% | +16.9% |
| Q1 2016 | $10,692,000 | -1.8% | 7,000,000 | 0.0% | 0.07% | +2.9% |
| Q4 2015 | $10,893,000 | +20.0% | 7,000,000 | 0.0% | 0.07% | +9.5% |
| Q3 2015 | $9,074,000 | – | 7,000,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opera Trading Capital | 5,700,000 | $8,208,000 | 2.47% |
| TFG Asset Management GP Ltd | 8,100,000 | $11,729,000 | 2.33% |
| Mint Tower Capital Management B.V. | 4,500,000 | $6,507,000 | 2.17% |
| BASSO CAPITAL MANAGEMENT, L.P. | 8,010,000 | $11,584,000 | 1.75% |
| CQS Cayman LP | 15,000,000 | $21,717,000 | 1.72% |
| LINDEN ADVISORS LP | 21,855,000 | $31,633,000 | 1.23% |
| CAMDEN ASSET MANAGEMENT L P /CA | 22,575,000 | $32,593,000 | 0.92% |
| Myriad Asset Management Ltd. | 9,000,000 | $13,045,000 | 0.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 25,000,000 | $36,172,000 | 0.64% |
| CSS LLC/IL | 5,500,000 | $7,955,000 | 0.43% |